These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 17934260

  • 1. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC, Yulugkural Z, Vahaboglu H.
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [Abstract] [Full Text] [Related]

  • 2. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
    Truong BX, Seo Y, Kato M, Hamano K, Ninomiya T, Katayama M, Kato H, Yano Y, Hayashi Y, Kasuga M.
    Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762
    [Abstract] [Full Text] [Related]

  • 9. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH, Song BC, Lee GC, Shin JW, Ryu SH, Jung SA, Yoo K, Lee HC, Lee YS, Suh DJ.
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.
    Fischler B, Nyström J, Björnsdottir T, Lindh G, Hultgren C.
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):75-83. PubMed ID: 17592368
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS, Perez RM, Medina-Pestana JO, Figueiredo MS, Koide S, Alberto FL, Silva AE, Ferraz ML.
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir.
    Reijnders JG, Rijckborst V, Sonneveld MJ, Scherbeijn SM, Boucher CA, Hansen BE, Janssen HL.
    J Hepatol; 2011 Mar; 54(3):449-54. PubMed ID: 21112655
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK, Papatheodoridis GV, Tiniakos DG, Hadziyannis ES, Agelopoulou OP, Syminelaki T, Papaioannou C, Nastos T, Karayiannis P.
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.
    Rodriguez-Frias F, Jardi R, Buti M, Schaper M, Hermosilla E, Valdes A, Allende H, Martell M, Esteban R, Guardia J.
    J Viral Hepat; 2006 May; 13(5):343-50. PubMed ID: 16637866
    [Abstract] [Full Text] [Related]

  • 17. [Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B].
    Yoo BC, Kim HJ, Do JH, Park SM.
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):381-8. PubMed ID: 12506242
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA, Quiroga JA, Subirá D, Castañón S, Esteban JM, Pardo M, Carreño V.
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [Abstract] [Full Text] [Related]

  • 19. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [Abstract] [Full Text] [Related]

  • 20. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P.
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.